Search research articles
Contact Us
Filters
Showing results (121-130 of 404) with videos related to
Page
of 41
Sort By:
The Canadian Journal of Cardiology
|
May 7, 2021
Improving Outcomes Following Catastrophic Cardiac Events During Transcatheter Aortic Valve Replacement
Harold L Lazar
JTCVS Open
|
August 25, 2022
Commentary: Extracorporeal membrane oxygenation: Is it life-saving and cost effective for all patients?
Harold L Lazar
Vascular Pharmacology
|
March 29, 2005
The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery
Harold L Lazar
Journal of Cardiac Surgery
|
August 3, 2018
Strokes are the achilles heel of LVAD therapy
Harold L Lazar
The Journal of Thoracic and Cardiovascular Surgery
|
February 26, 2019
Commentary: Inhibition of gene expression-A novel strategy for cerebral protection during deep hypothermic circulatory arrest
Harold L Lazar
The Annals of Thoracic Surgery
|
February 4, 1999
Angiotensin-converting enzyme inhibitors during acute revascularization
H L Lazar
The Annals of Thoracic Surgery
|
March 1, 2005
Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient
Harold L Lazar
The Canadian Journal of Cardiology
|
October 26, 2017
Mitral Stenosis After Mitral Valve Repair for Degenerative Mitral Regurgitation-Lessons Learned
Harold L Lazar
The Journal of Thoracic and Cardiovascular Surgery
|
January 27, 2018
Surgical site infections after coronary artery bypass grafting-Does "never" really mean "never"?
Harold L Lazar
The Canadian Journal of Cardiology
|
December 12, 2018
Limiting Readmissions Following Cardiac Surgery-A "Common Sense" Solution
Harold L Lazar
Page
of 41
Search research articles
Search
Showing results (121-130 of 404) with videos related to
Sort By:
Page
of 41
The Canadian Journal of Cardiology
|
May 7, 2021
Improving Outcomes Following Catastrophic Cardiac Events During Transcatheter Aortic Valve Replacement
Harold L Lazar
JTCVS Open
|
August 25, 2022
Commentary: Extracorporeal membrane oxygenation: Is it life-saving and cost effective for all patients?
Harold L Lazar
Vascular Pharmacology
|
March 29, 2005
The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery
Harold L Lazar
Journal of Cardiac Surgery
|
August 3, 2018
Strokes are the achilles heel of LVAD therapy
Harold L Lazar
The Journal of Thoracic and Cardiovascular Surgery
|
February 26, 2019
Commentary: Inhibition of gene expression-A novel strategy for cerebral protection during deep hypothermic circulatory arrest
Harold L Lazar
The Annals of Thoracic Surgery
|
February 4, 1999
Angiotensin-converting enzyme inhibitors during acute revascularization
H L Lazar
The Annals of Thoracic Surgery
|
March 1, 2005
Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient
Harold L Lazar
The Canadian Journal of Cardiology
|
October 26, 2017
Mitral Stenosis After Mitral Valve Repair for Degenerative Mitral Regurgitation-Lessons Learned
Harold L Lazar
The Journal of Thoracic and Cardiovascular Surgery
|
January 27, 2018
Surgical site infections after coronary artery bypass grafting-Does "never" really mean "never"?
Harold L Lazar
The Canadian Journal of Cardiology
|
December 12, 2018
Limiting Readmissions Following Cardiac Surgery-A "Common Sense" Solution
Harold L Lazar
Page
of 41